A second trial confirms two pills beat chemo when EGFR lung cancer escapes through MET
In a phase 3 trial published Oct. 26, 2026, in the Journal of Clinical Oncology, people with EGFR lung cancer that escaped EGFR pills through MET amplification went a median 6.2 months…